Home > News > Biophan Expands Biotechnology IP Portfolio to 114 Patents
March 29th, 2005
Biophan Expands Biotechnology IP Portfolio to 114 Patents
Abstract:
Biophan Technologies, Inc., a developer of next-generation biomedical technology, has announced continued growth of its intellectual property portfolio, reaching a total of 114 issued or filed patents in a range of cutting-edge biomedical fields. The newly-issued patents and recent patent applications claim important additional intellectual property coverage for the Company as it continues its development of advanced solutions for Magnetic Resonance Imaging (MRI) safety and image compatibility for surgical instruments and implanted devices, and other markets.
Source:
businesswire
Bookmark:
| Related News Press |
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||